Available online on 15.11.2026 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2026 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article                                                           Review Article

Mastagi (Pistacia lentiscus): A Comprehensive Evidence-Based Review of Traditional Uses and Modern Pharmacological Perspectives

Jamal Akhtar 1*, Aeliya Rukhsar 2, Ram Pratap Meena 3

1 Ph D Scholar at Centre of Excellence Jamia Hamdard and Research officer in Central Council for Research in Unani Medicine, Ministry of Ayush, New Delhi

2 Research Associate in Central Council for Research in Unani Medicine, Ministry of Ayush, Government of India, New Delhi. 

 3Assistant Director (Chemistry), in Central Council for Research in Unani Medicine, Ministry of Ayush, Government of India, New Delhi. 

Article Info:

______________________________________________ Article History:

Received 13 Aug 2026  

Reviewed 27 Sep 2026  

Accepted 19 Oct 2026  

Published 15 Nov 2026  

______________________________________________

Cite this article as:

Akhtar J, Rukhsar A, Meena RP, Mastagi (Pistacia lentiscus): A Comprehensive Evidence-Based Review of Traditional Uses and Modern Pharmacological Perspectives, Journal of Drug Delivery and Therapeutics. 2026; 16(11):73-81  DOI: https://doi.org/10.22270/jddt.v16i11.8053                                                            ______________________________________________

For Correspondence:  

Jamal Akhtar, Ph D Scholar at Centre of Excellence Jamia Hamdard and Research officer in Central Council for Research in Unani Medicine, Ministry of Ayush, New Delhi

Abstract

___________________________________________________________________________________________________________________

Background: Pistacia lentiscus L. (Mastagi) is an aromatic medicinal plant traditionally used in Unani medicine, particularly for gastrointestinal disorders, wounds, and ulcers. Objective: To review the traditional uses, phytochemical constituents, and pharmacological activities of P. lentiscus. Methods: Information was compiled from classical Unani literature and published experimental and clinical studies concerning the botanical characteristics, traditional uses, Phytochemistry, and pharmacological properties of P. lentiscus. Results: P. lentiscus contains diverse bioactive constituents, including monoterpenes, triterpenes, phenolics, flavonoids, fatty acids, tocopherols, and sterols. Experimental studies have reported antimicrobial, antioxidant, anti-inflammatory, gastroprotective, Hepatoprotective, hypolipidaemic, antidiabetic, anticancer, neuroprotective, and wound-healing activities. Conclusion: The available evidence supports several traditional uses of P. lentiscus and indicates considerable pharmacological potential. However, evidence is predominantly preclinical, and further well-designed clinical and safety studies are required to establish its therapeutic efficacy.

Keywords: Pistacia lentiscus; Mastagi; mastic gum; Unani medicine; Phytochemistry; pharmacological activity.


 

 


 

1. Introduction

Pistacia lentiscus L. (Mastagi), commonly known as the mastic tree, is an aromatic medicinal plant that grows to a height of 1–5 m1. It is an evergreen perennial shrub belonging to the family Anacardiaceous1. The tree bears bright red globose berries, and mastic gum is the natural resin obtained from its stem2,3. Mastic is a resin or more correctly an oleoresin containing little oil obtained from a cultivated variety of Pistacia lentiscus in the Greek Island of Chios4. Mastic comes in peppercorn-sized, rigid, microscopic rips. Most are pear-shaped, avoid globular, or almost globular, and occasionally, but infrequently, they are elongated. The medicine has a mildly acceptable taste and an agreeable, slightly aromatic odour, both of which are characteristics5. The resin occurs as small, hard, pear-shaped, ovoid or nearly globular, sometimes elongated tears, about 2–8 mm in diameter. The tears are pale yellow and brittle, break with a clear, glossy fracture, are transparent inside and crush to a sandy powder. The taste is slightly agreeable and the odour aromatic6, 7.

 

Table: - 1- Kingdom, division, class, order, genus, species and family of Pistacia. Lentiscus7

Kingdom

Plantae

Subkingdom

Viridiplantae

Division

Tracheophyta

Class

Magnoliopsida

Order

Sapindales

Family

Anacardiaceae

Genus

Pistacia

Species

P. lentiscus

 

Vernacular names8 

Table: - 2 – Vernacular names, Mizaj, Part used and Miqdar-e-Khurak of Pistacia. Lentiscus8

Arabic

Mastake, Ilk-ur-Roomi, Mastagi

Urdu

Mastagi

English

Mastic tree, Mastic

Hindi

Rumi Mastagi, Rumi Mastaki, Mastagi

Tamil

Ponnuikan, Kungiliyam

Persian

Kundur Roomi

Bengali

Rumi-Mastungi

Marathi

Ruma Mastakee, Roomi Mastakhi

Gujarati

Rumi Mastagee

Mizaj (temperament)

Har wa Yabis (hot and dry) in the second degree9

Parts used

Resin obtained from the stem of P. lentiscus 

Miqdar-e-Khurak (dose)

2–7 g10

2. Habitat and Distribution

Native to the Mediterranean region (France, Spain, Portugal, Greece, Turkey) and also found in North Africa. Mostly mastic is produced on the Greek Island of Chios, some is also produced in Algeria, Morocco and the Canary Island11. Growing in countries bordering on the Mediterranean, its resin is called the mastiche and obtained by incisions made in the bark, is imported into India from Asia Minor through Persia and Afghanistan11,12.

3. Ethnobotanical description

P. lentiscus L. is widely distributed in Mediterranean countries such as Morocco and the Iberian Peninsula, and is cultivated in France, Turkey, Iraq, Iran and England. Its resin is imported into India from Asia Minor through Iran and Afghanistan7. The aromatic, ivory-coloured resin, known as mastic, is harvested as a spice from cultivated mastic trees on the Greek island of Chios, where it is also known as ‘Chios tears’. The resin is originally liquid and dries in the sun into hard, brittle, translucent drops; when chewed, it softens and becomes a bright white, opaque gum13.

Mahiyat (Unani morphology)

In Unani literature, Mastagi is a resin popularly known as ‘Alakur-rome’ and is imported from foreign countries. It resembles Kundur but is more effective and lighter. Two varieties are described. The first, Mastagi Romi, is white, transparent, fragrant, sweet, very soft and sticky; the resin exudes naturally from the bark of the tree. This variety is of superior quality and has a shelf life of about 20 years. The second, Qabti, is black, less transparent, bitter and hard14.

Afal (Pharmacological actions)

Mastagi has various important pharmacological actions like Muhallil-e-Auram (Anti-inflammatory), Kasir-e-Riyah (Carminative), Mushtahi (Appetizer), Mujaffif-e-Rutoobat (Siccative), Musakhkhin (Calorific), Mulayyin (Laxative agent), Qabiz (Astrigent), Mulattif (Demulcent), Jali (Detergent), Muqawwi-e-Aam (General tonic), Muqawwi-e-Meda (Stomach Tonic), Muqawwi-e-Aza-e-Raisa (Tonic to Vital organs), Mufatteh-e-Sudad (Deobstruent), Mufarreh Qalb (Exhillarant), Musakkin-e-Alam (Analgesic), Mundamil-e-Qurooh, (Cicatrizant), Munaffis-e-Balgham (Expectorant), Mudirr-e-Baul (Diuretic), Jazib-e-Rutoobat (Absorbant), Habis-e-Dam (Heamostatic), Habis-e-Ishal (Anti-diarrhoeal)14,15.

Mahall-e-Istemal (Therapeutic uses)

Mastagi has numerous beneficial therapeutic indications based on their actions Jarah waqurooh(Wound and Ulcers), Zof-e-Hazam (Indigestion), Zof-e-Jigar (Weakness of Liver), Nafakh-e-Shikam (Flatulence), Zof-e-Badan (General Weakness), Suda-e-Barid (Headache), Qarha-e-Am’a (Intestinal ulcer), Zof-e-Ishtiha (Anorexia), Jarb (Scabies), Sailan-e-Dam-e-Rahem (Uterine bleeding), Razz (Contusion), Zarba wa Saqta (Strain and Sprain), Ehtibas-e-Baul (Urine Retention), Nafs-ud-Dam (Heamoptysis)14,15.

 

4. Chemical constituents

The mastic gum of Pistacia lentiscus contains approximately 2% essential oil. Essential oil obtained from samples originating from Spain has been reported to contain about 90% monoterpene hydrocarbons, with α-pinene (79%) as the predominant constituent, followed by myrcene (3%). The resin is primarily composed of triterpenes, including mastic acid, isomastic acid, oleanolic acid, and tirucallol. A lyophilized aqueous extract of the aerial parts has also been reported to contain steroid-triterpenes, catechin tannins, flavonoids, saponins, resins, and sugars7. The resin contains a diverse range of terpenoids and related derivatives, including 1,8-cineole, isoterpinolene, α-cubebene, α-ylangene, α-copaene, β-bourbonene, valencene, germacrene D, β-caryophyllene, α-longipinene, γ-gurjunene, α-amorphene, α-humulene, isocaryophyllene, β-cubebene, β-patchoulene, α-muurolene, γ-muurolene, guaiene, β-selinene, γ-elemene, cyclostivene, 17-(acetyloxy)kauran-19-al, pyrethrin I, (−)-spathulenol, ledol, megastigmatriene, allethrin, cubenol, and 16-kaurene, together with several other terpenoid derivatives. The essential oil of P. lentiscus is characterized predominantly by α-pinene, β-myrcene, β-pinene, limonene, and β-caryophyllene4. The fixed oil obtained from ripe seeds is rich in monounsaturated fatty acids (52.4%), with oleic acid (51.06%) being the major fatty acid, followed by linoleic acid (20.71%). The seed oil is also particularly rich in α-tocopherol, which accounts for approximately 97% of the total tocopherol content, while β-sitosterol has been reported as the predominant sterol16. The leaves are rich in phenolic compounds. Galloyl quinic acid derivatives, quercetin and kaempferol glucosides, luteolin and neo-rehmannioside have been identified by UHPLC–HRMS17, and the flavonol glycosides myricetin-3-O-rhamnoside, quercetin-3-O-rhamnoside and kaempferol-3-O-rhamnoside have been isolated from distilled leaves18,19. Gallic acid is the predominant compound in both leaf and fruit extracts, and luteolin was reported for the first time in the fruits20. The berries contain phenolics and flavonoids as well as anthocyanins, tannins, saponins, terpenoids, proteins and mucilage21,22. Among the bioactive triterpenoids, oleanolic acid and 24Z-isomasticadienolic acid have been reported from P. lentiscus23. The phytochemical content varies with altitude: in leaves from Morocco, lower altitudes increased polyphenol and flavonoid yields, whereas higher sites favoured ascorbic acid, chlorophylls and tannins24.

Microwave-assisted extraction (MAE) of phenolic compounds from P. lentiscus leaves was optimized using response surface methodology with a Box Behnken design. The optimum conditions (46% ethanol, 60 s extraction time, 17.86 W/mL power density and a 28:1 liquid-to-solid ratio) yielded 185.69 ± 18.35 mg GAE/g dry weight of total phenolic. Compared with ultrasound-assisted and conventional solvent extraction, the optimized MAE produced higher levels of total phenolic, flavonoids and tannins, with comparable antioxidant activity in the ABTS assay17,25.


 

 

                 image

Figure 2. Major classes of metabolites reported from Pistacia lentiscus: volatiles, triterpenes, phenolics, phytosterols, fatty acids and carotenoids, with representative structures.

 


 

5. Evidence-based pharmacological actions

Anti-atherogenic and hypolipidaemic activity

Dedoussis et al.26 investigated the molecular mechanisms through which the total polar extract of P. lentiscus var. chia resin inhibits the cytotoxic effect of oxidized low-density lipoprotein (ox LDL) on peripheral blood mononuclear cells (PBMCs). Cells exposed to ox LDL underwent apoptosis and necrosis, depending on the duration of exposure, and concurrent culture with the polar extract inhibited both phenomena. Ox LDL decreased glutathione (GSH) levels and upregulated CD36 expression, whereas the extract restored GSH levels and downregulated CD36 expression, even at the mRNA level, thus exhibiting antiatherogenic efficacy. The triterpenoid fraction showed particularly strong GSH-restoring activity.

In hypercholesterolaemic animals given 200 mg/kg for 30 days, an ethanolic leaf extract with a higher flavonoid content significantly reduced total cholesterol, triglycerides and LDL-cholesterol, whereas the aqueous extract significantly lowered total cholesterol and triglycerides27.

Antimicrobial activity

Antibacterial activity. Mezni et al.28 studied oil extracted from mature fruits collected in northern Tunisia, using a traditional method practised by women in forest areas and a pressing method. Gas chromatography mass spectrometry showed that oleic acid was the main fatty acid (more than 56%), followed by palmitic acid (27%). Pressing improved antioxidant activity. Antibacterial activity was tested against Escherichia coli, Salmonella typhimurium and Clostridium perfringens: a significant bactericidal effect was observed against C. perfringens, particularly with pressed oil from Bizerte, but not against E. coli or S. typhimurium.

In an in vitro study, extracts of P. lentiscus were tested against the bacteria Sarcina lutea, Staphylococcus aureus and E. coli and the fungi Candida albicans, Candida parapsilosis, Torulopsis glabrata and Cryptococcus neoformans. Decoctions showed the best antibacterial activity, but the activity against fungal cells appeared much more interesting29.

Aqueous and flavonoid enriched extracts and the essential oil obtained from the leaves were assessed against six bacterial strains. A significant effect was observed against S. typhimurium, whereas lower activity was seen against S. aureus, Pseudomonas aeruginosa and Salmonella enteritidis. The essential oil showed significant inhibitory effects against S. typhimurium, S. enteritidis and S. aureus30. In a comparison against antibiotic-resistant strains, the methanolic leaf extract, which was richer in phenolics and flavonoids than the aqueous extract, showed stronger antibacterial and antioxidant effects, with notable activity against P. aeruginosa31. The essential oil of var. chia was active against E. coli, S. aureus and Bacillus subtilis, and minor constituents such as verbenone, α-terpineol and linalool contributed substantially to this effect, suggesting synergistic interactions among its components4. Activity against Helicobacter pylori. Mastic resin was bactericidal against all tested H. pylori strains, including metronidazole-resistant strains, at 0.06 mg/mL within 24 hours; lower concentrations suppressed bacterial growth and produced a post-antibiotic effect32. In a microdilution assay on clinical isolates, mastic gum killed 50% of strains at 125 µg/mL and 90% at 500 µg/mL. Transmission electron microscopy of cells exposed to sub-bactericidal concentrations showed blebbing, morphological abnormalities and cellular fragmentation33. In a randomized pilot clinical study, mastic gum eradicated H. pylori in 4/13 and 5/13 patients at two different doses; this was less effective than standard triple therapy (10/13 patients), but mastic gum was well tolerated34. Oral pathogens. Mastic gum produced clear growth-inhibition zones against Streptococcus mutans and other mutans streptococci and was non-cytotoxic to HEp-2 cells at the concentrations used. In 25 healthy volunteers, chewing mastic gum significantly reduced salivary mutans streptococci compared with placebo gum (p < 0.001), and the effect persisted for more than two hours35. In orthodontic patients with fixed appliances, a 15-minute chewing period significantly reduced salivary S. mutans and total bacterial counts; after 135 minutes, S. mutans, lactobacilli and total viable bacteria were all significantly lower than with placebo gum (p < 0.001)36. In a three-week study of 42 adults, pure, xylitol-containing and probiotic mastic gums all significantly reduced salivary mutans streptococci (p < 0.001); pure and xylitol mastic raised salivary pH, whereas probiotic mastic lowered it, which may be unfavourable for dental health37. Among the compounds tested against oral pathogens and C. albicans, oleanolic acid from P. lentiscus showed the strongest broad-spectrum activity, particularly against Porphyromonas gingivalis and other anaerobes23. A narrative review concluded that polyphenol-rich P. lentiscus extracts show stronger antimicrobial activity than other plant derivatives, particularly against periodontal pathogens and C. albicans, and may be useful in toothpastes and mouthwashes38.

Antifungal activity. Crude leaf extracts of P. lentiscus, P. vera and P. terebinthus significantly inhibited the growth of the plant pathogens Pythium ultimum and Rhizoctonia solani, but no appreciable activity was seen against Fusarium sambucinum39.

Antimutagenic and antigenotoxic activity

Hayder et al.30 demonstrated the antimutagenic activity of different extracts against aflatoxin B1 (AFB1) and sodium azide using the Salmonella typhimurium assay. The number of revertants per plate decreased significantly when the plant extracts were added to the assay system using strains TA100, TA98 and TA1535. Fruit extracts showed no genotoxicity in the SOS chromotest with E. coli PQ37, with or without microsomal activation; the ethyl acetate fraction and the total oligomeric flavonoids significantly reduced AFB1- and nifuroxazide-induced genotoxicity and showed strong DPPH radical-scavenging activity40.

Antioxidant activity

Many herbal therapies are used to treat liver disease, jaundice or diabetes, conditions in which oxidative stress is prominent. Ljubuncic et al.41 selected eight plants used to treat these conditions in traditional Arab medicine and assessed their antioxidant potential by measuring their ability to suppress iron-induced lipid peroxidation in rat liver homogenates. Their potential toxicity was evaluated through effects on mitochondrial respiration and cell-membrane integrity in cultured PC12 and HepG2 cells. All the extracts suppressed iron-induced lipid peroxidation and none was toxic; the extracts of Teucrium polium and P. lentiscus were the most effective.

The antioxidant properties of galloyl quinic acid derivatives isolated from P. lentiscus leaves have been investigated by electron paramagnetic resonance (EPR) spectroscopy and UV–Vis spectrophotometry, and estimated using the biologically relevant LDL oxidation test. The scavenging activities of gallic acid and the 5-O-galloyl, 3,5-O-digalloyl and 3,4,5-O-trigalloylquinic acid derivatives were estimated against the 1,1-diphenyl-2-picrylhydrazyl (DPPH), superoxide and hydroxyl radicals. Scavenging activity increased with the number of galloyl groups on the quinic acid skeleton, and the half-inhibition concentrations (IC₅₀) of the di- and tri-galloyl derivatives did not exceed 30 µM for any of the radicals tested. All the tested metabolites strongly reduced LDL oxidation, following a trend similar to that observed for hydroxyl radical scavenging42.

Other studies have confirmed the antioxidant potential of the leaves. Ethanolic leaf extracts showed higher antiradical activity than those of Pistacia atlantica, although lower than ascorbic acid43. The ethyl acetate leaf extract showed the strongest DPPH and hydroxyl radical scavenging and reducing activity, while the methanolic extract showed the highest inhibition of β-carotene bleaching (94%); both showed anti-lipid peroxidation activity, closely associated with their phenolic and flavonoid contents44. Methanolic extracts of leaves and fruits showed DPPH scavenging above 73%, with IC₅₀ values of 0.121 ± 0.001 mg/mL for leaves and 0.26 ± 0.0002 mg/mL for fruits45. Among nine Mediterranean medicinal plants, the leaves of P. lentiscus and Myrtus communis showed the highest DPPH-scavenging activity, and P. lentiscus leaves also inhibited β-carotene bleaching by 43.02%46. In Tunisian plants, the methanol/water (8:2) leaf extract had the highest phenolic content (124.1 mg GAE/g dry weight) and a DPPH-scavenging potency exceeding that of BHT47. Leaf and fruit extracts also showed strong ORAC activity and protected cells against H₂O₂-induced oxidative stress, with maximum protection at 100 µg/mL48. In Moroccan leaves, DPPH-scavenging activity correlated positively with total polyphenol content, and total antioxidant capacity with flavonoid concentration24.

The berries, oil and resin are also antioxidant. The ethanolic berry extract showed strong DPPH and ABTS radical-scavenging activity and notable reducing power, attributed mainly to its phenolic and flavonoid content21. The vegetable oil contained phenolics (122.72 ± 1.16 mg GAE/g) and flavonoids (18.41 ± 0.43 mg QE/g) and scavenged DPPH radicals (IC₅₀ = 37.38 µg/mL), although less effectively than ascorbic acid (IC₅₀ = 27.20 µg/mL)49. In oil substrates, the resin of var. chia showed significant antioxidant effects, particularly in virgin olive oil and lard, and acted synergistically with citric acid in sunflower and corn oils, suggesting possible applications as a natural antioxidant in functional foods, pharmaceuticals and cosmetics50.

Neuroprotective activity

Co-administration of the leaf extract (150 and 300 ppm) for two months in male mice significantly improved anxiety-related behaviour and memory performance and attenuated aluminium-induced histopathological changes. In vitro, the extract and its phenolic constituents, particularly myricetin rhamnoside, quercetin rhamnoside, gallic acid, myricetin and quercetin, reduced lipid peroxidation in synaptosomal membranes, with myricetin rhamnoside the most active (IC₅₀ = 0.04 mM)51. In addition, P. lentiscus leaves showed 73.84% acetylcholinesterase inhibition in an enzyme-inhibition screen of nine Mediterranean plants46.

Anticancer activity

Balan et al.52 reported that a 50% ethanol extract of Chios mastic gum (CMG) contains compounds that inhibit proliferation and induce death of HCT116 human colon cancer cells in vitro. CMG treatment induced cell-cycle arrest at G1, detachment of the cells from the substrate, activation of pro-caspases-8, -9 and -3, and several morphological changes typical of apoptosis in cell organelles. These events were time- and dose-dependent but p53- and p21-independent. Apoptosis induction was not inhibited in HCT116 clones expressing high levels of the anti-apoptotic protein Bcl-2 or dominant-negative FADD, indicating that CMG induces cell death through a yet-to-be-identified pathway unrelated to the death-receptor and mitochondrion-dependent pathways. The findings suggest that CMG induces an anoikis form of cell death involving caspase-dependent events and might be developed into a chemotherapeutic agent for colon and other cancers.

In vivo, intraperitoneal administration of a hexane extract of mastic gum (200 mg/kg for four consecutive days, followed by a three-day treatment-free interval) reduced the growth of HCT116 xenografts in SCID mice by approximately 35% over 35 days without significant toxicity53. Dietary mastic oil from var. chia inhibited the proliferation and migration of colon carcinoma cells and reduced survivin expression; oral administration suppressed tumour growth in mice, with decreased Ki-67 and survivin levels. The complete mastic oil (67.7% α-pinene and 18.8% myrcene) showed significant antitumour activity, whereas the individual compounds or their combination did not, suggesting a synergistic effect of its terpene constituents54. Mastic oil also inhibited the proliferation of K562 leukaemia cells and promoted apoptosis, while reducing VEGF release, endothelial cell proliferation and microvessel formation in vitro and in vivo; these effects were associated with suppression of Erk1/2 activation in leukaemia cells and of RhoA signalling in endothelial cells55.

Leaf and fruit extracts have also shown antiproliferative activity. The methanol/water (8:2) leaf extract was cytotoxic to CaCo-2 and AGS cells (IC₅₀ = 135.67 ± 2.5 and 250.45 ± 1.96 µg/mL, respectively), whereas infusion extracts were inactive47, and leaf and fruit extracts inhibited the growth of B16F10 melanoma cells (IC₅₀ = 56.40 and 58.04 µg/mL, respectively)48.

Hepatoprotective effect

The boiled and non-boiled aqueous extracts of P. lentiscus, Phillyrea latifolia and Nicotiana glauca were evaluated in carbon tetrachloride (CCl₄)-intoxicated rats. The extracts were administered orally at a dose of 4 mL/kg body weight and contained various amounts of solid matter. Only the non-boiled aqueous extract of N. glauca leaves reduced total serum bilirubin, while the boiled and non-boiled extracts of N. glauca flowers were ineffective. Bilirubin and alkaline phosphatase (ALP) activity were both reduced by the boiled aqueous extract of P. latifolia, without reducing alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity. Both aqueous extracts of P. lentiscus showed marked antihepatotoxic activity against CCl₄, reducing the activity of all three enzymes and the bilirubin level, and the effect of the non-boiled extract was more pronounced than that of the boiled extract56.

Leaf and fruit extracts also protected mice against paracetamol-induced liver injury, improving hepatic biochemical markers and reducing histological damage; the leaf extract showed the stronger overall activity, which was attributed to its higher phenolic content20.

The evidence is, however, not uniform. An aqueous leaf extract with proven in vitro antioxidant activity induced hepatic fibrosis, inflammation, mild cholestasis and glutathione depletion when administered for a prolonged period to healthy rats, and it aggravated these effects in thioacetamide-treated animals57. This finding highlights the need for caution regarding prolonged use of aqueous leaf extracts.

Gastrointestinal protective and anti-ulcer activity

The effect of mastic obtained from the stem of P. lentiscus was studied in experimentally induced gastric and duodenal ulcers in rats. Mastic at an oral dose of 500 mg/kg significantly reduced the intensity of gastric mucosal damage induced by pyloric ligation, aspirin, phenylbutazone, reserpine and restraint plus cold stress. It significantly decreased free acidity in 6-h pylorus-ligated rats and had a marked cytoprotective effect against 50% ethanol, which was reversed by prior treatment with indomethacin. The protective effect was not seen when mastic was given intraperitoneally in the phenylbutazone and restraint plus cold stress models, and the reduction in ulceration in cysteamine-induced duodenal ulcers was not statistically significant in mastic-pretreated rats. The results imply that a mild antisecretory action and a localized adaptive cytoprotective action may be responsible for its anti-ulcer activity58.

In a clinical study of benign gastric ulcers, oral mastic gum gave significant symptomatic relief and accelerated endoscopic healing without side effects59. Its activity against H. pylori, including metronidazole-resistant strains, may also contribute to its anti-ulcer effects32. Leaf extracts have shown similar protection: chloroform, ethyl acetate and methanolic leaf extracts significantly reduced HCl/ethanol-induced gastric lesions in rats in a dose-dependent manner after oral administration60, and an aqueous leaf extract dose-dependently attenuated colonic tissue damage, oxidative stress and inflammatory changes in acetic acid-induced colitis in rats61.

Anti-inflammatory activity

The alcoholic leaf extract reduced croton oil-induced ear oedema by 65% and vascular permeability by 46%, compared with 51% and 28%, respectively, for the aqueous extract. Both extracts significantly suppressed carrageenan-induced pleurisy and inhibited neutrophil chemotaxis and elastase activity in vitro62. Intraperitoneal administration of aqueous, chloroform, ethyl acetate and methanolic leaf extracts produced dose-dependent anti-inflammatory effects in carrageenan-induced paw oedema in rats60, and the leaf extract also showed significant anti-inflammatory activity in cell-based assays48. The acetonic extract of the fruits has been evaluated for topical and oral anti-inflammatory activity in the croton oil-induced ear oedema model in mice, in comparison with indomethacin63.

Hypotensive activity

A lyophilized aqueous extract of P. lentiscus caused a dose-dependent decrease in systemic arterial blood pressure in normotensive, urethane-anaesthetized Wistar rats22.

Antiarthritic and antigout activity

The total phenolic contents of the leaves and bark of Fraxinus angustifolia and of the leaves and seeds of P. lentiscus were estimated. The aqueous fractions of P. lentiscus obtained from hexane and chloroform extractions and the aqueous fraction of F. angustifolia obtained from ethyl acetate extraction inhibited xanthine oxidase (XO) activity by 72.74 ± 2.63% (IC₅₀ = 27.52 µg/mL), 68.97 ± 3.89% (IC₅₀ = 42.46 µg/mL) and 53.92 ± 3.17% (IC₅₀ = 58.84 µg/mL), respectively, at 100 µg/mL, compared with 98.18% (IC₅₀ = 6.34 µg/mL) for the reference drug allopurinol. At 50 µg/mL, both P. lentiscus extracts showed inhibition rates above 50%, whereas F. angustifolia leaf extracts showed only mild inhibition. Lineweaver–Burk analysis showed that the inhibition by the aqueous extracts of F. angustifolia bark and P. lentiscus was of mixed type, whereas F. angustifolia leaf extracts inhibited XO non-competitively. XO inhibition correlated positively with total phenols (r = 0.89) and flavonoids (r = 0.93) for P. lentiscus, and with total phenols (r = 0.72) and tannins (r = 0.54) for F. angustifolia64.

Antidiabetic activity

P. lentiscus is a Mediterranean shrub rich in phenolic and flavonoid compounds. Evidence from in vitro and in vivo studies indicates that it exerts antidiabetic effects through multiple therapeutic targets, highlighting its potential as a multitarget natural agent for the management of type 2 diabetes65. The fruit extract has also shown antidiabetic activity and α-amylase inhibition20.

Wound healing and dermatological activity

Boulebda et al.66 evaluated the effect of P. lentiscus fruit fatty oil on cutaneous wound healing in rats and compared it with that of its saponifiable and unsaponifiable oily fractions. Full-thickness excision wounds were made on the back of anaesthetized rats. The fruit oil and the two fractions were assessed together with a conventional drug, Madecassol®. The preparations were applied topically to the wounded area once a day and assessed over 26 days, during which wound area was measured and photographically documented. Wound contraction was significantly enhanced (p < 0.05) by P. lentiscus oil, the unsaponifiable oily fraction and Madecassol compared with untreated control animals, and the effect was most pronounced in the group treated with the unsaponifiable fraction.

Flavonol glycosides from distilled leaves (myricetin-3-O-rhamnoside and quercetin-3-O-rhamnoside) permeated the cutaneous membrane in transdermal diffusion tests, and these compounds and the crude extract significantly inhibited tyrosinase and elastase at non-cytotoxic concentrations in B16 melanoma cells, indicating potential as a cosmeceutical ingredient for skin pigmentation and loss of elasticity18.

6. Conclusion

Mastagi (P. lentiscus) has a long history of use in Unani medicine, and a broad body of experimental evidence supports its antimicrobial, antioxidant, anti-inflammatory, gastroprotective, hepatoprotective, hypolipidaemic, antidiabetic and anticancer effects. Most of this evidence, however, comes from in vitro and animal studies, and clinical data are limited to small studies on H. pylori eradication, gastric ulcers and oral health. The conflicting hepatic findings with aqueous leaf extract underline the need for rigorous safety and dose-finding studies before clinical use can be recommended.

Funding source: The author declares that no funding was received for this study.

Authors’ Contribution: Conceptualization, Writing Original Draft & Investigation: Jamal Akhtar

Supervision: Ram Pratap Meena 

Methodology, Review & Editing: Aeliya Rukhsar

Acknowledgments: The authors are grateful to the Central Council for Research in Unani Medicine (CCRUM), New Delhi, for providing the necessary facilities and support.

Conflicts of Interest: The author declares no conflict of interest.

References

1.  Sastri BN. The wealth of India: raw materials. Vol. 6. New Delhi: Council of Scientific and Industrial Research; 1962. p. 439.

2.  Central Council for Research in Unani Medicine (CCRUM). National formulary of Unani medicine. Part I, Vol. I. New Delhi: Ministry of Health and Family Welfare, Government of India; 2006. p. 34, 70, 74, 84, 124.

3.  Evans WC, Evans D. Trease and Evans pharmacognosy. 16th ed. Toronto: Elsevier Saunders; 2009. p. 27.

4. Koutsoudaki C, Krsek M, Rodger A. Chemical composition and antibacterial activity of the essential oil and the gum of Pistacia lentiscus var. chia. J Agric Food Chem. 2005;53(20):7681-5. https://doi.org/10.1021/jf050639s PMid:16190616

5.  Greenish HG. Materia medica. 3rd ed. Jodhpur: Scientific Publisher (India); 1999. p. 469.

6.  Kirtikar KR, Basu BD. Indian medicinal plants. 2nd ed. Vol. 3. Dehradun: International Book Publishers and Distributors; 2008. p. 2149-50.

7. Khare CP. Indian medicinal plants: an illustrated dictionary. New York: Springer Science+Business Media; 2007. p. 62, 494-5. https://doi.org/10.1007/978-0-387-70638-2 PMCid:PMC2705749

8.  Khare CP. Encyclopedia of Indian medicinal plants: rational Western therapy, Ayurvedic and other traditional usage, botany. New York: Springer; 2004. p. 371-2.

9.  Khan MA. Muheet-e-Azam. Vol. 1. New Delhi: Central Council for Research in Unani Medicine; 2011.

10.    Ibn Baitar. Al-Jamiul mufradat al-advia wal-aghzia. Vol. 2 (Urdu translation). New Delhi: Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare; 2000. p. 170-3, 333-5.

11.    Lawless J. Complete essential oils. Shaftesbury, Dorset: Element Books Limited; 1999. 202 p.

12.    Anonymous. Hamdard pharmacopoeia of Eastern medicine. Said HM, editor. Delhi: Sri Satguru Publications; 1997. p. 310-411.

13.    Nadkarni KM. Indian materia medica: with Ayurvedic, Unani-Tibbi, Siddha, allopathic, homeopathic, naturopathic and home remedies, and volume I. Bombay: Popular Prakashan; 1976. p. 972-4.

14.    Ghani N. Khazain-ul-Advia. Part 6. New Delhi: Central Council for Research in Unani Medicine (CCRUM); 2010. p. 228-9, 290-4.

15.    Aziz MA. Mufradat-e-Azizi. New Delhi: Central Council for Research in Unani Medicine; 2009

16. Dhifi W, et al. Chemical composition of lentisk (Pistacia lentiscus L.) seed oil. Afr J Agric Res. 2013;8(16):1395-400. https://doi.org/10.5897/AJAR11.1837

17. Bampouli A, et al. Evaluation of total antioxidant potential of Pistacia lentiscus var. chia leaves extracts using UHPLC-HRMS. J Food Eng. 2015;167:25-31. https://doi.org/10.1016/j.jfoodeng.2014.10.021

18. Elloumi W, et al. Pistacia lentiscus L. distilled leaves as a potential cosmeceutical ingredient: phytochemical characterization, transdermal diffusion, and anti-elastase and anti-tyrosinase activities. Molecules. 2022;27:855. https://doi.org/10.3390/molecules27030855 PMid:35164116 PMCid:PMC8838631

19. Elez Garofulić I, et al. Evaluation of polyphenolic profile and antioxidant activity of Pistacia lentiscus L. leaves and fruit extract obtained by optimized microwave-assisted extraction. Foods. 2020;9:1556. https://doi.org/10.3390/foods9111556 PMid:33121196 PMCid:PMC7692612

20. Mehenni C, et al. Hepatoprotective and antidiabetic effects of Pistacia lentiscus leaf and fruit extracts. J Food Drug Anal. 2016;24:653-69. https://doi.org/10.1016/j.jfda.2016.03.002 PMid:28911573 PMCid:PMC9336671

21. Belhachat D, et al. Phytochemical screening and in vitro antioxidant activity of Pistacia lentiscus berries ethanolic extract growing in Algeria. Mediterr J Nutr Metab. 2017;10:273-85. https://doi.org/10.3233/MNM-17169

22. Villar A, Sanz MJ, Payá M. Hypotensive effect of Pistacia lentiscus L.. Int J Crude Drug Res. 1987;25(1):1-3. https://doi.org/10.3109/13880208709060902

23. Karygianni L, et al. Compounds from Olea europaea and Pistacia lentiscus inhibit oral microbial growth. BMC Complement Altern Med. 2019;19:1-10. https://doi.org/10.1186/s12906-019-2461-4 PMid:30808354 PMCid:PMC6390541

24. Bendada M, et al. Evaluation of phytochemical content and in vitro antioxidant activities of Pistacia lentiscus L. leaves extracts, a medicinal plant from the Beni-Snassen forest (Eastern Region of Morocco). Scientifica (Cairo). 2024;2024:9999175. https://doi.org/10.1155/2024/9999175 PMid:39483359 PMCid:PMC11527531

25. Dahmoune F, et al. Pistacia lentiscus leaves as a source of phenolic compounds: microwave-assisted extraction optimized and compared with ultrasound-assisted and conventional solvent extraction. Ind Crops Prod. 2014;61:31-40. https://doi.org/10.1016/j.indcrop.2014.06.035

26. Dedoussis GVZ, et al. Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis. 2004;174:293-303. https://doi.org/10.1016/j.atherosclerosis.2004.02.011 PMid:15136059

27. Cheurfa M, Allem R. Study of hypocholesterolemic activity of Algerian Pistacia lentiscus leaves extracts in vivo. Rev Bras Farmacogn. 2015;25:142-4. https://doi.org/10.1016/j.bjp.2015.02.011

28. Mezni F, et al. Fatty acid composition, antioxidant and antibacterial activities of Pistacia lentiscus L. fruit oils. J Med Plants Res. 2012;6(39):5266-71. https://doi.org/10.5897/JMPR12.473

29. Iauk L, et al. In vitro antimicrobial activity of Pistacia lentiscus L. extracts: preliminary report. J Chemother. 1996;8(3):207-9. https://doi.org/10.1179/joc.1996.8.3.207 PMid:8808717

30. Hayder N, et al. Antibacterial and antimutagenic activity of extracts and essential oil from (Tunisian) Pistacia lentiscus. Toxicol Environ Chem. 2005;87(4):567-73. https://doi.org/10.1080/02772240500399823

31. Alhadad A, et al. Assessments of antibacterial and antioxidant properties in the methanolic and aqueous leaf extracts of Pistacia lentiscus against different antibiotic resistance pathogenic bacteria. Adv Biosci Biotechnol. 2022;13:113-33. https://doi.org/10.4236/abb.2022.133005

32. Huwez FU, et al. Mastic gum kills Helicobacter pylori. N Engl J Med. 1998;339(26):1946. https://doi.org/10.1056/NEJM199812243392618 PMid:9874617

33. Marone P, et al. Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J Chemother. 2001;13(6):611-4. https://doi.org/10.1179/joc.2001.13.6.611 PMid:11806621 PMCid:PMC8838553

34. Dabos KJ, et al. The effect of mastic gum on Helicobacter pylori: a randomized pilot study. Phytomedicine. 2010;17(3-4):296-9. https://doi.org/10.1016/j.phymed.2009.09.010 PMid:19879118

35. Aksoy A, Duran N, Koksal F. In vitro and in vivo antimicrobial effects of mastic chewing gum against Streptococcus mutans and mutans streptococci. Arch Oral Biol. 2006;51(6):476-81. https://doi.org/10.1016/j.archoralbio.2005.11.003 PMid:16343417

36. Aksoy A, et al. Short-term effect of mastic gum on salivary concentrations of cariogenic bacteria in orthodontic patients. Angle Orthod. 2007;77(1):124-8. https://doi.org/10.2319/122205-455R.1 PMid:17029554

37.    Biria M, et al. Effects of three mastic gums on the number of mutans streptococci, lactobacilli and pH of the saliva. J Dent (Tehran). 2014;11(6):672-9.

38. Milia EP, Sardellitti L, Eick S. Antimicrobial efficiency of Pistacia lentiscus L. derivates against oral biofilm-associated diseases - a narrative review. Microorganisms. 2023;11(6):1378. https://doi.org/10.3390/microorganisms11061378 PMid:37374880 PMCid:PMC10305426

39. Kordali S, et al. Antifungal activities of the leaves of three Pistacia species grown in Turkey. Fitoterapia. 2003;74:164-7. https://doi.org/10.1016/S0367-326X(02)00320-9 PMid:12628416

40. Abdelwahed A, et al. Antigenotoxic and antioxidant activities of fruit extracts from (Tunisian) Pistacia lentiscus. Food Sci Technol Int. 2009;15:215-22. https://doi.org/10.1177/1082013208339705

41. Ljubuncic P, et al. Antioxidant activity and cytotoxicity of eight plants used in traditional Arab medicine in Israel. J Ethnopharmacol. 2005;99(1):43-7. https://doi.org/10.1016/j.jep.2005.01.060 PMid:15848018

42. Baratto MC, et al. Antioxidant activity of galloyl quinic acid derivatives isolated from Pistacia lentiscus leaves. Free Radic Res. 2003;37(4):405-12. https://doi.org/10.1080/1071576031000068618 PMid:12747734

43.    Benhammou N, Bekkara FA, Panovska TK. Antiradical capacity of the phenolic compounds of Pistacia lentiscus L. and Pistacia atlantica Desf.. Adv Food Sci. 2007;29(3):155-61.

44. Saliha D, et al. Antioxidant proprieties of Pistacia lentiscus L. leaves extracts. Pharmacogn Commun. 2013;3:28. https://doi.org/10.5530/pc.2013.2.7

45.    Hemma R, et al. Antioxidant activity of Pistacia lentiscus methanolic extracts. Rev Agrobiologia. 2018;8:845-52.

46. Amessis-Ouchemoukh N, et al. Antioxidant capacity and phenolic contents of some Mediterranean medicinal plants and their potential role in the inhibition of cyclooxygenase-1 and acetylcholinesterase activities. Ind Crops Prod. 2014;53:6-15. https://doi.org/10.1016/j.indcrop.2013.12.008

47. Yemmen M, et al. Antioxidant activities, anticancer activity and polyphenolic profile, of leaf, fruit and stem extracts of Pistacia lentiscus from Tunisia. Cell Mol Biol. 2017;63:87-95. https://doi.org/10.14715/cmb/2017.63.9.16 PMid:28980927

48. Remila S, et al. Antioxidant, cytoprotective, anti-inflammatory and anticancer activities of Pistacia lentiscus (Anacardiaceae) leaf and fruit extracts. Eur J Integr Med. 2015;7:274-86. https://doi.org/10.1016/j.eujim.2015.03.009

49.    Bouyahya A, et al. Phenolic contents and antiradical capacity of vegetable oil from Pistacia lentiscus (L.). J Mater Environ Sci. 2018;9:1518-24.

50. Assimopoulou AN, Zlatanos SN, Papageorgiou VP. Antioxidant activity of natural resins and bioactive triterpenes in oil substrates. Food Chem. 2005;92:721-7. https://doi.org/10.1016/j.foodchem.2004.08.033

51. Azib L, et al. Pistacia lentiscus L. leaves extract and its major phenolic compounds reverse aluminium-induced neurotoxicity in mice. Ind Crops Prod. 2019;137:576-84. https://doi.org/10.1016/j.indcrop.2019.05.062

52. Balan KV, et al. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia. Phytomedicine. 2007;14(4):263-72. https://doi.org/10.1016/j.phymed.2006.03.009 PMid:16713222

53.    Dimas K, et al. A mastic gum extract induces suppression of growth of human colorectal tumor xenografts in immunodeficient mice. In Vivo. 2009;23:63-8.

54. Spyridopoulou K, et al. Dietary mastic oil extracted from Pistacia lentiscus var. chia suppresses tumor growth in experimental colon cancer models. Sci Rep. 2017;7(1):1-14. https://doi.org/10.1038/s41598-017-03971-8 PMid:28630399 PMCid:PMC5476564

55. Loutrari H, et al. Mastic oil from Pistacia lentiscus var. chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. Nutr Cancer. 2006;55(1):86-93. https://doi.org/10.1207/s15327914nc5501_11 PMid:16965245

56. Janakat S, Al-Merie H. Evaluation of hepatoprotective effect of Pistacia lentiscus, Phillyrea latifolia and Nicotiana glauca. J Ethnopharmacol. 2002;83(1-2):135-8. https://doi.org/10.1016/S0378-8741(02)00241-6 PMid:12413719

57. Ljubuncic P, et al. The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease. J Ethnopharmacol. 2005;100(1-2):198-204. https://doi.org/10.1016/j.jep.2005.03.006 PMid:16054533

58. Al-Said MS, et al. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol. 1986;15(3):271-8. https://doi.org/10.1016/0378-8741(86)90165-0 PMid:3724207

59. Huwez FU, Al-Habbal MJ. Mastic in treatment of benign gastric ulcers. Gastroenterol Jpn. 1986;21:273-4. https://doi.org/10.1007/BF02774571 PMid:3732760

60. Dellai A, et al. Antiinflammatory and antiulcerogenic activities of Pistacia lentiscus L. leaves extracts. Ind Crops Prod. 2013;49:879-82. https://doi.org/10.1016/j.indcrop.2013.07.010

61. Zahouani Y, et al. Aqueous leaf extract of Pistacia lentiscus improves acute acetic acid-induced colitis in rats by reducing inflammation and oxidative stress. J Med Food. 2021;24:697-708. https://doi.org/10.1089/jmf.2020.0020 PMid:33156733

62. Bouriche H, et al. Anti-inflammatory and immunomodulatory properties of Pistacia lentiscus extracts. J Appl Pharm Sci. 2016;6:140-6. https://doi.org/10.7324/JAPS.2016.60721

63.    Bouriche H, et al. Anti-inflammatory activity of acetonic extract of Pistacia lentiscus fruits. TOJSAT. 2013;3:40-8.

64. Berboucha M, et al. Kinetic study on the inhibition of xanthine oxidase by extracts from two selected Algerian plants traditionally used for the treatment of inflammatory diseases. J Med Food. 2010;13(4):896-904. https://doi.org/10.1089/jmf.2009.0164 PMid:20553185

65. Floris S, et al. Pistacia lentiscus: phytochemistry and antidiabetic properties. Nutrients. 2024;16(11):1638. https://doi.org/10.3390/nu16111638 PMid:38892571 PMCid:PMC11174566

66.    Boulebda N, Belkhiri A, Belfadel F, Bensegueni A, Bahri L. Dermal wound healing effect of Pistacia lentiscus fruit’s fatty oil. Pharmacogn Res. 2009;1(2):66-78.

67.    Abdul Hakeem HM. Bustan-ul-Mufridat. New Delhi: Idara Kitab-us-Shifa; [date unknown]. p. 316-7.

68.    Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH). The Unani pharmacopoeia of India. Part II, Vol. I. New Delhi: Ministry of Health and Family Welfare, Government of India; 2009. p. 71.

69.    Khan MA. Muheet-e-Azam. Vol. 4. New Delhi: Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare, Government of India; 2018. p. 215-20.

70.    Khan MA. Muheet-e-Azam. Vol. 4. New Delhi: Central Council for Research in Unani Medicine; 2014. p. 538-9.

71.    Nadkarni KM. Indian plants and drugs. New Delhi: Srishti Book Distributors; 2005. p. 50.

72.    Prajapati D, Purohit S, Sharma A, Kumar T. A handbook of medicinal plants. New Delhi: Agrobios; 2003. p. 448-9.